Skip to content

ENCOMPASS: Expansion Study A, RCT

Enhancing Community Health Through Patient Navigation, Advocacy and Social Support (ENCOMPASS): Expansion Study A, A Randomized Controlled Trial With Waitlist Control

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04790604
Acronym
ENCOMPASS
Enrollment
96
Registered
2021-03-10
Start date
2021-01-22
Completion date
2023-07-03
Last updated
2024-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Diabetes Mellitus, Type 2, Hypertension, Ischemic Heart Disease

Keywords

Chronic Disease, Health Navigation, Health Navigator

Brief summary

Some patients living with multiple long-term health conditions have difficulty accessing the services they need, despite available primary care and community resources. Patient navigation programs may help those with complex health conditions to improve their care and outcomes. Community health navigators (CHNs) are community members who help guide patients through the health care system. CHNs are not health professionals like a doctor or nurse, but they are specially trained to help patients get the most out of their health care and connect them to resources. The ENCOMPASS program of research evaluates a patient navigation program that connects patients living with long-term health conditions to CHNs. To understand if the CHN program can be scaled to a provincial level, the ENCOMPASS program of research is expanding to select primary care settings across Alberta. This study implements and evaluates the CHN program at Edmonton Oliver Primary Care Network in Edmonton, Alberta, Canada.

Detailed description

Community Health Navigators (CHNs) are defined as community health workers that provide patient navigation. Based on evidence to date, CHNs for chronic disease management are likely to beneficially impact patient experience, clinical outcomes and costs; however, contextual evidence is lacking given that most studies to date have been conducted in the United States. In Canada, patient navigation programs currently exist in only a few settings (primarily cancer treatment and transitional care), with few navigation programs implemented in chronic disease care. The ENCOMPASS program of research was initiated in 2016, when researchers with the University of Calgary's Interdisciplinary Chronic Disease Collaboration partnered with Mosaic Primary Care Network (PCN) to develop, implement and evaluate a community health navigation program for patients with multiple chronic conditions. The program was based on a systematic literature review and refined in consultation with key stakeholders. A cluster-randomized controlled trial is currently ongoing with Mosaic PCN to determine the impact of the program on acute care use, patient-reported outcomes and experience, and disease-specific clinical outcomes (NCT03077386). Alberta Primary Care Networks (PCNs) are comprised of groups of family physicians and other health care professionals working together to provide comprehensive patient care to Albertans. To understand if the community health navigation program can be feasibly scaled and spread to PCNs across Alberta, we are expanding research to examine and evaluate community health navigation program implementation to other geographic areas and populations. This study expands the ENCOMPASS program of research to Edmonton Oliver PCN, which represents over 170 physician members and serves approximately 131,000 patients. The current study employs the RE-AIM framework (reach, effectiveness, adoption, implementation, and maintenance) to examine the scalability of the community health navigation program. The objectives of this study are to (1) assess the impact of the intervention on the target population and health system (effectiveness); (2) explore the feasibility and appropriateness of practical intervention scale-up (reach, adoption, implementation, and maintenance), and (3) identify the required resources and infrastructure necessary to maintain and scale the intervention provincially. The effectiveness of the community health navigator program will be studied using a two-armed, pragmatic, randomized waitlist-controlled trial. This study will employ patient-level block randomization with research staff blinded to block size. Randomization will be concealed and computer-generated. Primary outcomes will be assessed using administrative health data. Secondary outcomes will be measured using a patient health survey administered by a research assistant at baseline, 6 months, and 12 months. A concurrent qualitative study will provide contextual information on the effectiveness of the community health navigator program from patient, provider, and CHN perspectives. Process evaluation metrics and interviews with program stakeholders will inform the feasibility and sustainability of the community health navigator program in Alberta PCNs.

Interventions

Patients will be matched to a community health navigator (CHN) who will conduct a needs assessment to determine the frequency of meetings. A CHN may perform any of the following: providing information to a patient's health care provider, translation, advocating for the patient, connecting the patient with resources (e.g., social, financial, insurance), helping patients set health-related goals, facilitating health care referrals and appointments, and monitoring appointments. These activities may require the CHN to be physically present at appointments or have direct contact with the patient's health care provider. Goal setting and support will be provided in-person or over the telephone using motivational interviewing principles.

Sponsors

University of Alberta
CollaboratorOTHER
University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

The ENCOMPASS study will evaluate the effectiveness of a community health navigator program using a two-armed, pragmatic, randomized waitlist-controlled trial. The intervention arm will receive the CHN program for six months. The waitlist control arm will have a six month waiting period followed by six months of CHN program. This study will employ patient-level block randomization. Research staff will be blinded to block size. In the case where participants live together in the same residence, they will be randomly assigned to the same study arm.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Poorly controlled hypertension (most recent systolic blood pressure \> 160 mmHg or labile); * Poorly controlled diabetes (A1C \> 9% on at least one occasion within the past year or labile); * Stage 3b or greater chronic kidney disease (estimated glomerular filtration rate \< 45 mL/min/1.73m2 in past year); * Established ischemic heart disease (at least one instance of a physician billing diagnosis with a relevant International Classification of Diseases, 9th Edition \[ICD-9\] code recorded in electronic medical record (EMR), or known to health care team); * Congestive heart failure (at least one instance of a physician billing diagnosis with a relevant ICD-9 code recorded in EMR, or known to health care team); * Chronic obstructive pulmonary disease OR Asthma with at least two visits in the past year (at least 2 instances of a physician billing diagnosis with a relevant ICD-9 code, or known to health care team).

Exclusion criteria

* Patient unable to provide informed consent; * Patient residing in long-term care facility; * Health care provider discretion.

Design outcomes

Primary

MeasureTime frameDescription
Acute care service useUp to 36 monthsRate of emergency department visits and hospital admissions based on administrative health data.

Secondary

MeasureTime frameDescription
Patient experience of careUp to 12 months11-item modified Patient Assessment of Chronic Illness Care (PACIC).
Patient activationUp to 12 months10-item Patient Activation Measure (PAM-10), score and level.
Anxiety symptomsUp to 12 months7-item Generalized Anxiety Disorder (GAD-7).
Depressive symptomsUp to 12 months9-item Patient Health Questionnaire (PHQ-9).
Perceived social supportUp to 12 months8-item modified Medical Outcomes Study Social Support Survey (mMOS-SS).
Health literacyUp to 12 months3-item Brief Screening Questions for Health Literacy.
General self-rated healthUp to 12 months1-item Self-Rated Health (SRH).
Household food securityUp to 12 months6-item Household Food Security Survey Module (HFSSM).
Smoking statusUp to 12 monthsSelf-reported smoking status.
WeightUp to 12 monthsChange in self-reported weight in kilograms or pounds.
Disease-specific intermediate health outcomes: DiabetesUp to 24 monthsChange in mean glycosylated hemoglobin (A1C) based on laboratory data.
Disease-specific intermediate health outcomes: HypertensionUp to 12 monthsChange in systolic blood pressure (SBP) in mmHg based on primary data collection.
Health-related quality of lifeUp to 12 monthsEuroQol EQ-5D-5L.
Disease-specific intermediate health outcomes: COPD/asthmaUp to 24 monthsExacerbations based on administrative health data.
Disease-specific intermediate health outcomes: Ischemic heart disease, chronic kidney disease, diabetesUp to 24 monthsAppropriate use of a statin where indicated based on pharmaceutical information network (PIN) dispensation data.
Patient experienceUp to 12 monthsBased on semi-structured interviews.
Provider satisfactionUp to 12 monthsBased on semi-structured interviews.
Continuity of careUp to 24 monthsProvider attachment based on Usual Provider of Care (UPC) Index in Alberta practitioners claims file.
Primary Care Network (PCN) multidisciplinary team accessUp to 24 monthsNumber of visits to multidisciplinary health team members based on PCN records.
Program costsUp to 24 monthsAdministrative, training, and operational costs of program.
Physician costsUp to 24 monthsPhysician claims based on physician claims files.
Acute care costsUp to 24 monthsHospital admission and emergency department visit costs based on administrative health data.
All-cause mortalityUp to 24 monthsAll-cause mortality rate based on administrative data.
Medication adherenceUp to 24 months≥80% of days covered for medications in Care Plan based on pharmaceutical information network (PIN) dispensation data.
Disease-specific intermediate health outcomes: Heart failureUp to 24 monthsEpisodes of acutely decompensated heart failure based on administrative health data.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026